Heme Metabolism

Heme biosynthesis requires succinyl CoA, glycine, and ferrous ion as key substrates. Propionic acid is not involved in heme synthesis - it's a fatty acid that can be converted to succinyl CoA via propionyl CoA, but is not a direct reactant.

Aminolevulinic acid (ALA) synthase is the rate-limiting enzyme in heme synthesis, and its transcription can be induced by certain drugs (like barbiturates) through cytochrome P450 induction. It requires pyridoxal phosphate (not NAD), is inhibited by heme (feedback inhibition), and steroids don't directly inhibit its synthesis.

Ferrochelatase is the final enzyme in heme synthesis, inserting ferrous iron into protoporphyrin IX. Heavy metals like lead inhibit ferrochelatase activity, which is why lead poisoning causes anemia. It doesn't chelate iron therapeutically, degrade hemoglobin, or bind to sulfide ions.

Lead poisoning inhibits both ferrochelatase and ALA dehydratase in the heme synthesis pathway, causing accumulation of aminolevulinic acid (ALA) upstream. This occurs because the blocked pathway prevents ALA conversion to downstream products like heme.

Cholangiocarcinoma is a cancer of the bile ducts that causes obstruction to bile flow. This obstruction prevents conjugated bilirubin (direct bilirubin) from being excreted into the intestine, causing it to accumulate in the blood instead. Indirect (unconjugated) bilirubin is not typically elevated in cholangiocarcinoma unless there is also hemolysis or liver dysfunction.

Heme oxygenase is the enzyme that catalyzes the first step in heme degradation, which is the oxidation of the methene bridge between the pyrrole rings. This cleavage produces biliverdin, free iron, and carbon monoxide (not carbon dioxide). The enzyme does require molecular oxygen for its activity, but option A describes the core catalytic function more specifically.

In jaundice, both unconjugated bilirubin and conjugated bilirubin (bilirubin diglucuronide) can deposit in tissues including skin and sclera. The type that accumulates depends on the underlying cause: unconjugated bilirubin in hemolytic jaundice or conjugated bilirubin in obstructive jaundice. Biliverdin is not typically responsible for the yellow coloration seen in jaundice.

Acute intermittent porphyria (AIP) is characterized by elevated levels of porphobilinogen (PBG) and aminolevulinic acid (ALA) in the urine during acute attacks. This occurs due to a deficiency in porphobilinogen deaminase, causing accumulation of heme precursors proximal to the block. PBG is a specific diagnostic marker for AIP and can be detected by Watson-Schwartz test or Hoeffmann's test.

Dubin-Johnson syndrome is a conjugated hyperbilirubinemia caused by defective transport of conjugated bilirubin into the bile canaliculi. The defect is in the MRP2 (multidrug resistance-associated protein 2) transporter, not in UDP glucuronyl transferase (which is deficient in Crigler-Najjar syndrome) or hepatic uptake (defective in Rotor syndrome). The liver appears black due to melanin-like pigment deposition.

Porphyria cutanea tarda (PCT) is the most common type of porphyria and is associated with exposure to certain chemicals (alcohol, estrogen, hexachlorobenzene) and drugs. It is caused by decreased activity of uroporphyrinogen decarboxylase, leading to accumulation of uroporphyrin. This enzyme defect causes the characteristic blistering skin lesions and photosensitivity seen in PCT.

In a jaundiced patient, elevated alkaline phosphatase (ALP) suggests obstructive (cholestatic) jaundice. Gall stones are a common cause of extrahepatic biliary obstruction. The obstruction causes ALP (which is present in biliary epithelium) to leak into the bloodstream. Hepatic carcinoma would also elevate ALP but is less common than gallstones. Hemolytic anemia and pancreatitis do not typically cause elevated ALP.

This 'EXCEPT' question asks which statement is FALSE. Normal urine does NOT contain bilirubin - its absence is one of the key differences between normal urine and the urine of patients with liver disease. All other statements are true: urobilogen is formed in the intestine by bacterial action, unconjugated bilirubin is lipophilic, and bilirubin diglucuronide (conjugated bilirubin) is synthesized in the liver. Only conjugated bilirubin appears in urine when the renal threshold is exceeded.

In heme synthesis, the first three enzymes (ALA synthase, ALA dehydratase, and porphobilinogen deaminase) are cytosolic, while the later enzymes (including coproporphyrinogen oxidase, protoporphyrinogen oxidase, and ferrochelatase) are mitochondrial. ALA dehydratase (also known as porphobilinogen synthase) catalyzes the condensation of two ALA molecules to form porphobilinogen in the cytosol, making it the correct answer.

Acute intermittent porphyria (AIP) is caused by a deficiency of porphobilinogen deaminase (also known as hydroxymethylbilane synthase), which is the third enzyme in the heme biosynthesis pathway. This deficiency causes accumulation of porphobilinogen and ALA, leading to acute neurovisceral attacks. The other enzymes listed are deficient in different types of porphyria: uroporphyrinogen III cosynthase in congenital erythropoietic porphyria, protoporphyrinogen oxidase in variegate porphyria, and coproporphyrinogen oxidase in hereditary coproporphyria.

Ferrochelatase is the final enzyme in the heme biosynthesis pathway, inserting iron into protoporphyrin IX to form heme. ALA synthase, while rate-limiting, is not considered the regulatory enzyme in erythroid cells where feedback inhibition by heme is less prominent.

Acute intermittent porphyria (AIP) is characterized by abdominal pain, neuropsychiatric symptoms, and urine that darkens on standing due to porphobilinogen oxidation. Photosensitivity is NOT a feature of AIP - it occurs in cutaneous porphyrias like porphyria cutanea tarda and erythropoietic protoporphyria.

A biphasic reaction in the Vandenbergh test indicates both hepatocellular damage and partial obstruction. Viral hepatitis causes hepatocellular injury with some degree of cholestasis, resulting in this mixed pattern. Pure obstruction (stones, pancreatic head carcinoma) gives a purely positive reaction, while pure hemolysis gives a negative reaction.

This patient has predominantly direct (conjugated) hyperbilirubinemia (14/26 mg/dl) with bile salts and pigments in urine but absent urobilinogen. This pattern is classic for obstructive jaundice where conjugated bilirubin cannot enter the intestine and thus no urobilinogen is formed. Hemolytic jaundice shows unconjugated hyperbilirubinemia with increased urobilinogen.